Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 275

1.

ALK-1 protein expression and ALK gene rearrangements aid in the diagnosis of inflammatory myofibroblastic tumors of the female genital tract.

Fuehrer NE, Keeney GL, Ketterling RP, Knudson RA, Bell DA.

Arch Pathol Lab Med. 2012 Jun;136(6):623-6. doi: 10.5858/arpa.2011-0341-OA.

PMID:
22646268
2.

Utility of ALK-1 protein expression and ALK rearrangements in distinguishing inflammatory myofibroblastic tumor from malignant spindle cell lesions of the urinary bladder.

Sukov WR, Cheville JC, Carlson AW, Shearer BM, Piatigorsky EJ, Grogg KL, Sebo TJ, Sinnwell JP, Ketterling RP.

Mod Pathol. 2007 May;20(5):592-603. Epub 2007 Mar 30.

3.

Epithelioid inflammatory myofibroblastic sarcoma: An aggressive intra-abdominal variant of inflammatory myofibroblastic tumor with nuclear membrane or perinuclear ALK.

Mariño-Enríquez A, Wang WL, Roy A, Lopez-Terrada D, Lazar AJ, Fletcher CD, Coffin CM, Hornick JL.

Am J Surg Pathol. 2011 Jan;35(1):135-44. doi: 10.1097/PAS.0b013e318200cfd5.

PMID:
21164297
4.

Inflammatory myofibroblastic tumors of the urinary tract: a clinicopathologic study of 46 cases, including a malignant example inflammatory fibrosarcoma and a subset associated with high-grade urothelial carcinoma.

Montgomery EA, Shuster DD, Burkart AL, Esteban JM, Sgrignoli A, Elwood L, Vaughn DJ, Griffin CA, Epstein JI.

Am J Surg Pathol. 2006 Dec;30(12):1502-12.

PMID:
17122505
5.
6.

Inflammatory myofibroblastic tumor of the uterus: clinical and pathologic review of 10 cases including a subset with aggressive clinical course.

Parra-Herran C, Quick CM, Howitt BE, Dal Cin P, Quade BJ, Nucci MR.

Am J Surg Pathol. 2015 Feb;39(2):157-68. doi: 10.1097/PAS.0000000000000330.

PMID:
25321329
7.

Inflammatory myofibroblastic tumour of the urinary bladder: the role of immunoglobulin G4 and the comparison of two immunohistochemical antibodies and fluorescence in-situ hybridization for the detection of anaplastic lymphoma kinase alterations.

Choi E, Williamson SR, Montironi R, Zhang S, Wang M, Eble JN, Grignon DJ, Lopez-Beltran A, Idrees MT, Baldridge LA, Scarpelli M, Jones CL, Wang L, MacLennan GT, Osunkoya AO, Cheng L.

Histopathology. 2015 Jul;67(1):20-38. doi: 10.1111/his.12619. Epub 2015 Jan 29.

PMID:
25406945
8.
9.

Inflammatory myofibroblastic tumor with predominant anaplastic lymphoma kinase-positive cells lacking a myofibroblastic phenotype.

Hisaoka M, Shimajiri S, Matsuki Y, Meis-Kindblom JM, Kindblom LG, Li XQ, Wang J, Hashimoto H.

Pathol Int. 2003 Jun;53(6):376-81.

PMID:
12787312
10.

Polypoid laryngeal inflammatory myofibroblastic tumors: misleading lesions: description of six cases showing ALK overexpression.

Pierry C, Pérot G, Karanian-Philippe M, Neuville A, Gomez-Brouchet A, Crestani S, Coindre JM.

Am J Clin Pathol. 2015 Sep;144(3):511-6. doi: 10.1309/AJCPCG8D6JAQBVLG.

PMID:
26276782
11.

Expression of ROS1 predicts ROS1 gene rearrangement in inflammatory myofibroblastic tumors.

Hornick JL, Sholl LM, Dal Cin P, Childress MA, Lovly CM.

Mod Pathol. 2015 May;28(5):732-9. doi: 10.1038/modpathol.2014.165. Epub 2015 Jan 23.

12.

Inflammatory myofibroblastic tumor of the uterus: a clinicopathologic study of 6 cases emphasizing distinction from aggressive mesenchymal tumors.

Rabban JT, Zaloudek CJ, Shekitka KM, Tavassoli FA.

Am J Surg Pathol. 2005 Oct;29(10):1348-55.

PMID:
16160478
13.

Intraocular inflammatory myofibroblastic tumor with ALK overexpression.

O'Malley DP, Poulos C, Czader M, Sanger WG, Orazi A.

Arch Pathol Lab Med. 2004 Jan;128(1):e5-7.

PMID:
14692830
14.

Cytopathologic features of epithelioid inflammatory myofibroblastic sarcoma with correlation of histopathology, immunohistochemistry, and molecular cytogenetic analysis.

Lee JC, Wu JM, Liau JY, Huang HY, Lo CY, Jan IS, Hornick JL, Qian X.

Cancer Cytopathol. 2015 Aug;123(8):495-504. doi: 10.1002/cncy.21558. Epub 2015 Jul 2.

15.

Anaplastic lymphoma kinase immunoreactivity correlates with ALK gene rearrangement and transcriptional up-regulation in non-small cell lung carcinomas.

Boland JM, Erdogan S, Vasmatzis G, Yang P, Tillmans LS, Johnson MR, Wang X, Peterson LM, Halling KC, Oliveira AM, Aubry MC, Yi ES.

Hum Pathol. 2009 Aug;40(8):1152-8. doi: 10.1016/j.humpath.2009.01.012. Epub 2009 Apr 22.

PMID:
19386350
16.

Expression of anaplastic lymphoma kinase in soft tissue tumors: an immunohistochemical and molecular study of 249 cases.

Li XQ, Hisaoka M, Shi DR, Zhu XZ, Hashimoto H.

Hum Pathol. 2004 Jun;35(6):711-21.

PMID:
15188137
17.

Inflammatory myofibroblastic tumor of the lung in children: anaplastic lymphoma kinase (ALK) expression and clinico-pathological correlation.

Siminovich M, Galluzzo L, López J, Lubieniecki F, de Dávila MT.

Pediatr Dev Pathol. 2012 May-Jun;15(3):179-86. doi: 10.2350/11-10-1105-OA.1. Epub 2012 Jan 26.

PMID:
22280150
18.
19.

ALK-1 expression in inflammatory myofibroblastic tumor of the urinary bladder.

Tsuzuki T, Magi-Galluzzi C, Epstein JI.

Am J Surg Pathol. 2004 Dec;28(12):1609-14.

PMID:
15577680
20.

Inflammatory myofibroblastic tumor of the posterior mediastinum: an older adult case with anaplastic lymphoma kinase abnormalities determined using immunohistochemistry and fluorescence in situ hybridization.

Makimoto Y, Nabeshima K, Iwasaki H, Ishiguro A, Miyoshi T, Shiraishi T, Iwasaki A, Shirakusa T.

Virchows Arch. 2005 Apr;446(4):451-5. Epub 2005 Mar 19.

PMID:
15778844

Supplemental Content

Support Center